Breakthrough Infections This preprint retrospective analysis identifies risk factors associated with breakthrough infections using electronic health record from Columbia University Irving Medical Center/New York Presbyterian. The researchers aimed to address the following: What risk factors are associated with breakthrough infections?
Read More
COVID-19 Treatments – Safety and Efficacy There have been a number of emergency therapeutic interventions used for the treatment of both severe and non-severe COVID-19; none though that are formally accepted as a pharmacological treatment. These include ivermectin, avifavir, doxycycline,
Read More